Literature DB >> 11177672

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

I Olivotto1, B J Maron, F Cecchi.   

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with hypertrophic cardiomyopathy (HCM), and it bears numerous pathophysiologic consequences that potentially affect patient outcome and symptoms. However, studies regarding the impact of AF on the long-term prognosis of HCM patients have been limited in number, with sometimes conflicting results. Recently, studies on community-based patient populations showed that AF is associated with long-term clinical deterioration, embolic complications, and increased cardiovascular mortality due to heart failure and stroke. The consequences of AF on the long-term prognosis of HCM patients are not uniformly unfavorable, however, and in about one third of patients the arrhythmia is compatible with an uneventful course.

Entities:  

Mesh:

Year:  2001        PMID: 11177672     DOI: 10.1007/s11886-001-0041-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  46 in total

1.  Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation.

Authors:  M Higashikawa; Y Nakamura; M Yoshida; M Kinoshita
Journal:  Jpn Circ J       Date:  1997-08

Review 2.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology.

Authors:  S Lévy; G Breithardt; R W Campbell; A J Camm; J C Daubert; M Allessie; E Aliot; A Capucci; F Cosio; H Crijns; L Jordaens; R N Hauer; F Lombardi; B Lüderitz
Journal:  Eur Heart J       Date:  1998-09       Impact factor: 29.983

3.  Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

Authors:  J A Panza; R K Petrone; L Fananapazir; B J Maron
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

Review 4.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

Authors:  B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

5.  Heterogeneity of left ventricular filling dynamics in hypertrophic cardiomyopathy.

Authors:  M A Losi; S Betocchi; M Grimaldi; N Spampinato; M Chiariello
Journal:  Am J Cardiol       Date:  1994-05-15       Impact factor: 2.778

6.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation.

Authors:  P Spirito; E Lakatos; B J Maron
Journal:  Am J Cardiol       Date:  1992-05-01       Impact factor: 2.778

8.  Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

Authors:  C R Cannan; G S Reeder; K R Bailey; L J Melton; B J Gersh
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

9.  Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

Authors:  P T O'Gara; R O Bonow; B J Maron; B A Damske; A Van Lingen; S L Bacharach; S M Larson; S E Epstein
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

10.  Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry).

Authors:  A Cameron; M J Schwartz; R A Kronmal; A S Kosinski
Journal:  Am J Cardiol       Date:  1988-04-01       Impact factor: 2.778

View more
  6 in total

Review 1.  Hypertrophic cardiomyopathy as a cause of sudden death.

Authors:  Hubert Seggewiss; Christoph Blank; Barbara Pfeiffer; Angelos Rigopoulos
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

2.  Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population.

Authors:  Fredrik Holmqvist; Pyotr G Platonov; Jonas Carlson; Rasmus Havmöller; Johan E P Waktare; William J McKenna; S Bertil Olsson; Carl J Meurling
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

3.  Occupational asthma with paroxysmal atrial fibrillation in a diamond polisher.

Authors:  E Wilk-Rivard; J Szeinuk
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

4.  Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service.

Authors:  Objoon Trachoo; Teerapat Yingchoncharoen; Tawai Ngernsritrakul; Nareenart Iemwimangsa; Bhakbhoom Panthan; Sommon Klumsathian; Sasima Srisukh; Anucha Mukdadilok; Sithakom Phusanti; Angkana Charoenyingwattana; Takol Chareonsirisuthigul; Wasun Chantratita; Tarinee Tangcharoen
Journal:  PLoS One       Date:  2022-09-27       Impact factor: 3.752

5.  CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Authors:  Theano Papavassiliu; Tjeerd Germans; Stephan Flüchter; Christina Doesch; Anton Suriyakamar; Dariusch Haghi; Tim Süselbeck; Christian Wolpert; Dietmar Dinter; Stefan O Schoenberg; Albert C van Rossum; Martin Borggrefe
Journal:  J Cardiovasc Magn Reson       Date:  2009-09-09       Impact factor: 5.364

6.  Relation of atrial electromechanical delay to P-wave dispersion on surface ECG using vector velocity imaging in patients with hypertrophic cardiomyopathy.

Authors:  Hala Mahfouz Badran; Ghada Soltan; Eslam Eltahan; Magdi H Yacoub; Naglaa Faheem
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-09-24       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.